世界のレナリドマイド販売市場2021

QYResearchが発行した調査報告書(QYR21JN7759)
◆英語タイトル:Global Lenalidomide Sales Market Report 2021
◆商品コード:QYR21JN7759
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月20日
◆ページ数:139
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥532,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥798,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,064,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界のレナリドマイド市場について種類別(5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル)、用途別(多発性骨髄腫(MM)、骨髄異形成症候群(MDS))、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・レナリドマイド市場の概要
・世界の主要地域別レナリドマイド市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のレナリドマイド市場規模2016-2021:種類別(5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル)
・世界のレナリドマイド市場予測2012-2027:種類別(5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル)
・世界のレナリドマイド市場規模2016-2021:用途別(多発性骨髄腫(MM)、骨髄異形成症候群(MDS))
・世界のレナリドマイド市場予測2012-2027:用途別(多発性骨髄腫(MM)、骨髄異形成症候群(MDS))
・レナリドマイドのアメリカ市場規模と予測2016-2021
・レナリドマイドのヨーロッパ市場規模と予測2016-2021
・レナリドマイドの中国市場規模と予測2016-2021
・レナリドマイドの日本市場規模と予測2016-2021
・レナリドマイドの東南アジア市場規模と予測2016-2021
・レナリドマイドのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Celgene、Exova)
・レナリドマイドの製造コスト分析
・販売チャネル、流通業者、顧客
・レナリドマイドの市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Lenalidomide Market
The global Lenalidomide market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Lenalidomide Scope and Market Size
The global Lenalidomide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lenalidomide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
5 mg Capsules
10 mg Capsules
15 mg Capsules
25 mg Capsules

Segment by Application
Multiple myeloma (MM)
Myelodysplastic syndromes (MDS)

The Lenalidomide market is analysed and market size information is provided by regions (countries). Segment by Application, the Lenalidomide market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Celgene
Exova

【レポートの目次】

1 Lenalidomide Market Overview
1.1 Lenalidomide Product Scope
1.2 Lenalidomide Segment by Type
1.2.1 Global Lenalidomide Sales by Type (2016 & 2021 & 2027)
1.2.2 5 mg Capsules
1.2.3 10 mg Capsules
1.2.4 15 mg Capsules
1.2.5 25 mg Capsules
1.3 Lenalidomide Segment by Application
1.3.1 Global Lenalidomide Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Multiple myeloma (MM)
1.3.3 Myelodysplastic syndromes (MDS)
1.4 Lenalidomide Market Estimates and Forecasts (2016-2027)
1.4.1 Global Lenalidomide Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Lenalidomide Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Lenalidomide Price Trends (2016-2027)

2 Lenalidomide Estimates and Forecasts by Region
2.1 Global Lenalidomide Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Lenalidomide Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Lenalidomide Sales Market Share by Region (2016-2021)
2.2.2 Global Lenalidomide Revenue Market Share by Region (2016-2021)
2.3 Global Lenalidomide Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Lenalidomide Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Lenalidomide Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Lenalidomide Estimates and Projections (2016-2027)
2.4.2 Europe Lenalidomide Estimates and Projections (2016-2027)
2.4.3 China Lenalidomide Estimates and Projections (2016-2027)
2.4.4 Japan Lenalidomide Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Lenalidomide Estimates and Projections (2016-2027)
2.4.6 India Lenalidomide Estimates and Projections (2016-2027)
3 Global Lenalidomide Competition Landscape by Players
3.1 Global Top Lenalidomide Players by Sales (2016-2021)
3.2 Global Top Lenalidomide Players by Revenue (2016-2021)
3.3 Global Lenalidomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lenalidomide as of 2020)
3.4 Global Lenalidomide Average Price by Company (2016-2021)
3.5 Manufacturers Lenalidomide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Lenalidomide Market Size by Type
4.1 Global Lenalidomide Historic Market Review by Type (2016-2021)
4.1.1 Global Lenalidomide Sales Market Share by Type (2016-2021)
4.1.2 Global Lenalidomide Revenue Market Share by Type (2016-2021)
4.1.3 Global Lenalidomide Price by Type (2016-2021)
4.2 Global Lenalidomide Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Lenalidomide Sales Forecast by Type (2022-2027)
4.2.2 Global Lenalidomide Revenue Forecast by Type (2022-2027)
4.2.3 Global Lenalidomide Price Forecast by Type (2022-2027)
5 Global Lenalidomide Market Size by Application
5.1 Global Lenalidomide Historic Market Review by Application (2016-2021)
5.1.1 Global Lenalidomide Sales Market Share by Application (2016-2021)
5.1.2 Global Lenalidomide Revenue Market Share by Application (2016-2021)
5.1.3 Global Lenalidomide Price by Application (2016-2021)
5.2 Global Lenalidomide Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Lenalidomide Sales Forecast by Application (2022-2027)
5.2.2 Global Lenalidomide Revenue Forecast by Application (2022-2027)
5.2.3 Global Lenalidomide Price Forecast by Application (2022-2027)

6 North America Lenalidomide Market Facts & Figures
6.1 North America Lenalidomide Sales by Company
6.1.1 North America Lenalidomide Sales by Company (2016-2021)
6.1.2 North America Lenalidomide Revenue by Company (2016-2021)
6.2 North America Lenalidomide Sales Breakdown by Type
6.2.1 North America Lenalidomide Sales Breakdown by Type (2016-2021)
6.2.2 North America Lenalidomide Sales Breakdown by Type (2022-2027)
6.3 North America Lenalidomide Sales Breakdown by Application
6.3.1 North America Lenalidomide Sales Breakdown by Application (2016-2021)
6.3.2 North America Lenalidomide Sales Breakdown by Application (2022-2027)

7 Europe Lenalidomide Market Facts & Figures
7.1 Europe Lenalidomide Sales by Company
7.1.1 Europe Lenalidomide Sales by Company (2016-2021)
7.1.2 Europe Lenalidomide Revenue by Company (2016-2021)
7.2 Europe Lenalidomide Sales Breakdown by Type
7.2.1 Europe Lenalidomide Sales Breakdown by Type (2016-2021)
7.2.2 Europe Lenalidomide Sales Breakdown by Type (2022-2027)
7.3 Europe Lenalidomide Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)

8 China Lenalidomide Market Facts & Figures
8.1 China Lenalidomide Sales by Company
8.1.1 China Lenalidomide Sales by Company (2016-2021)
8.1.2 China Lenalidomide Revenue by Company (2016-2021)
8.2 China Lenalidomide Sales Breakdown by Type
8.2.1 China Lenalidomide Sales Breakdown by Type (2016-2021)
8.2.2 China Lenalidomide Sales Breakdown by Type (2022-2027)
8.3 China Lenalidomide Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)

9 Japan Lenalidomide Market Facts & Figures
9.1 Japan Lenalidomide Sales by Company
9.1.1 Japan Lenalidomide Sales by Company (2016-2021)
9.1.2 Japan Lenalidomide Revenue by Company (2016-2021)
9.2 Japan Lenalidomide Sales Breakdown by Type
9.2.1 Japan Lenalidomide Sales Breakdown by Type (2016-2021)
9.2.2 Japan Lenalidomide Sales Breakdown by Type (2022-2027)
9.3 Japan Lenalidomide Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Lenalidomide Market Facts & Figures
10.1 Southeast Asia Lenalidomide Sales by Company
10.1.1 Southeast Asia Lenalidomide Sales by Company (2016-2021)
10.1.2 Southeast Asia Lenalidomide Revenue by Company (2016-2021)
10.2 Southeast Asia Lenalidomide Sales Breakdown by Type
10.2.1 Southeast Asia Lenalidomide Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Lenalidomide Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Lenalidomide Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Lenalidomide Market Facts & Figures
11.1 India Lenalidomide Sales by Company
11.1.1 India Lenalidomide Sales by Company (2016-2021)
11.1.2 India Lenalidomide Revenue by Company (2016-2021)
11.2 India Lenalidomide Sales Breakdown by Type
11.2.1 India Lenalidomide Sales Breakdown by Type (2016-2021)
11.2.2 India Lenalidomide Sales Breakdown by Type (2022-2027)
11.3 India Lenalidomide Sales Breakdown by Application
11.3.1 India Lenalidomide Sales Breakdown by Application (2016-2021)
11.3.2 India Lenalidomide Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Lenalidomide Business
12.1 Celgene
12.1.1 Celgene Corporation Information
12.1.2 Celgene Business Overview
12.1.3 Celgene Lenalidomide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Celgene Lenalidomide Products Offered
12.1.5 Celgene Recent Development
12.2 Exova
12.2.1 Exova Corporation Information
12.2.2 Exova Business Overview
12.2.3 Exova Lenalidomide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Exova Lenalidomide Products Offered
12.2.5 Exova Recent Development

13 Lenalidomide Manufacturing Cost Analysis
13.1 Lenalidomide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Lenalidomide
13.4 Lenalidomide Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Lenalidomide Distributors List
14.3 Lenalidomide Customers

15 Market Dynamics
15.1 Lenalidomide Market Trends
15.2 Lenalidomide Drivers
15.3 Lenalidomide Market Challenges
15.4 Lenalidomide Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のレナリドマイド販売市場2021(Global Lenalidomide Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。